↓ Skip to main content

Dove Medical Press

Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report

Overview of attention for article published in OncoTargets and therapy, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
38 Mendeley
Title
Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report
Published in
OncoTargets and therapy, December 2018
DOI 10.2147/ott.s188612
Pubmed ID
Authors

Yan Zhang, Bixiu He, Dongbo Zhou, Min Li, Chengping Hu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 16%
Student > Ph. D. Student 6 16%
Other 4 11%
Student > Bachelor 3 8%
Professor 2 5%
Other 4 11%
Unknown 13 34%
Readers by discipline Count As %
Medicine and Dentistry 7 18%
Pharmacology, Toxicology and Pharmaceutical Science 4 11%
Biochemistry, Genetics and Molecular Biology 4 11%
Chemistry 3 8%
Agricultural and Biological Sciences 1 3%
Other 2 5%
Unknown 17 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2023.
All research outputs
#4,922,392
of 25,707,225 outputs
Outputs from OncoTargets and therapy
#220
of 3,013 outputs
Outputs of similar age
#100,829
of 448,038 outputs
Outputs of similar age from OncoTargets and therapy
#5
of 107 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,038 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.